CompletedNot applicableNCT04453917
Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy
Studying Progressive multifocal leukoencephalopathy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Toulouse
- Principal Investigator
- Guillaume MARTIN-BLONDELUniversity Hospital, Toulouse
- Intervention
- Collection of blood and urine(biological)
- Enrollment
- 22 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2024
Study locations (3)
- CHU Bordeaux, Bordeaux, France
- CHU Montpellier, Montpellier, France
- CHU de TOULOUSE, Toulouse, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04453917 on ClinicalTrials.govOther trials for Progressive multifocal leukoencephalopathy
Additional recruiting or active studies for the same condition.
See all trials for Progressive multifocal leukoencephalopathy →